Lu-177-PNT2002

Lutetium-177 PNT2002 · Lantheus Medical Imaging

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lu-177-PNT2002, covering 2025-01-13 to 2025-01-13. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Treatment with [Lu-177]-PNT2002 for Adult Patients with Prostate-Specific Membrane Antigen (PSMA)-Positive Metastatic Castration-Resistant Prostate Cancer (mCRPC)

See pricing